The executive director leads the staff of Global Fund, supervising and coordinating the management of grants, finances, resource mobilization, innovation, advocacy and staffing. The executive director reports directly to the Board, and is supported by a Management Executive Committee.
The executive director is appointed by the Board for a four-year term.
In November 2012, the Board selected Dr. Mark Dybul to serve as executive director. He began in January 2013.
Mark Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher and administrator. After graduating from Georgetown Medical School in Washington D.C., Dr. Dybul joined the National Institute of Allergy and Infectious Diseases, where he conducted basic and clinical studies on HIV virology, immunology and treatment optimization, including the first randomized, controlled trial with combination antiretroviral therapy in Africa.
Dr. Dybul became a founding architect and driving force in the formation of the President’s Emergency Plan for AIDS Relief, better known as PEPFAR. After serving as Chief Medical officer, Assistant, Deputy and Acting director, he was appointed as its leader in 2006, becoming U.S. Global AIDS Coordinator, with the rank of Ambassador at the level of an Assistant Secretary of State. He served until early 2009.
Before coming to the Global Fund, Dr. Dybul was co-director of the Global Health Law Program at the O’Neill Institute for National and Global Health Law at Georgetown University, where he was also a Distinguished Scholar. Dr. Dybul has written extensively in scientific and policy literature, and has received several Honorary Degrees and awards.